Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K, standard procedure, check for details.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on March 14, 2024, to report other events and financial statements. The filing does not contain specific details about new transactions or financial results in the provided text, but indicates the submission of required documentation.

Why It Matters

This filing serves as an official notification to the SEC and investors about significant corporate events or financial updates for Omega Healthcare Investors, Inc.

Risk Assessment

Risk Level: low — The filing is a routine disclosure and does not appear to contain negative news or significant changes.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — Registrant
• March 14, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.10 — f the Company's common stock, par value $0.10 per share (the "Common Stock") under th

Filing Documents

• tm248634d7_8k.htm (8-K) — 31KB
• tm248634d7_ex5-1.htm (EX-5.1) — 22KB
• tm248634d7_ex5-2.htm (EX-5.2) — 20KB
• tm248634d7_ex8-1.htm (EX-8.1) — 14KB
• tm248634d7_ex8-2.htm (EX-8.2) — 26KB
• 0001104659-24-034585.txt ( ) — 305KB
• ohi-20240314.xsd (EX-101.SCH) — 3KB
• ohi-20240314_lab.xml (EX-101.LAB) — 33KB
• ohi-20240314_pre.xml (EX-101.PRE) — 22KB
• tm248634d7_8k_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. On March 14, 2024, Omega Healthcare Investors, Inc. (the "Company"), filed with the U.S. Securities and Exchange Commission (the "SEC") an automatic shelf registration statement on Form S-3ASR (File No. 333-277916) (the "New Registration the SEC on May 13, 2021 (the "Prior Registration Statement"). The Prior Registration Statement was terminated upon the effectiveness of the New Registration Statement on March 14, 2024. In connection with the filing of the New Registration Statement, on March 14, 2024, the Company filed the following two prospectus supplements: (i) A prospectus supplement (the "DRCSPP Prospectus Supplement") relating to the Company's existing Dividend Reinvestment and Common Stock Purchase Plan (the "Plan") under the New Registration Statement. The DRCSPP Prospectus Supplement continues the offering of shares of the Company's common stock, par value $0.10 per share (the "Common Stock") under the Plan previously covered by a prospectus supplement filed August 5, 2021, under the Prior Registration Statement and registers an aggregate of 14,152,369 shares of Common Stock for issuance under the New Registration Statement. The Plan is designed to provide the Company's existing stockholders and interested new investors with a method of purchasing Common Stock and investing all or a percentage of their cash dividends in additional shares of Common Stock. (ii) A prospectus supplement (the "ATM Prospectus Supplement") relating to the Company's existing "at-the-market" equity offering sales agreement (the "Sales Agreement") with each of the institutions named therein (or certain of their respective affiliates or, as applicable, successors or assignees) in their capacity as Sales Agents, as Forward Sellers and/or as Forward Purchasers relating to (a) the issuance and sale by the Company to or through the Sales Agents, f

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 5.1 Opinion of Shapiro Sher Guinot & Sandler, P.A. (DRCSPP Prospectus Supplement) 5.2 Opinion of Shapiro Sher Guinot & Sandler, P.A. (ATM Prospectus Supplement) 8.1 Opinion of Bryan Cave Leighton Paisner LLP (DRCSPP Prospectus Supplement) 8.2 Opinion of Bryan Cave Leighton Paisner LLP (ATM Prospectus Supplement) 23.1 Consent of Shapiro Sher Guinot & Sandler P.A. (included in Exhibit 5.1) 23.2 Consent of Shapiro Sher Guinot & Sandler P.A. (included in Exhibit 5.2) 23.3 Consent of Bryan Cave Leighton Paisner LLP (included in Exhibit 8.1) 23.4 Consent of Bryan Cave Leighton Paisner LLP (included in Exhibit 8.2) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEGA HEALTHCARE INVESTORS, INC. Dated: March 14, 2024 By: /s/ Robert O. Stephenson Robert O. Stephenson Chief Financial Officer, Treasurer and Assistant Secretary

View Full Filing

View this 8-K filing on SEC EDGAR